Verma and colleagues interrogate the mechanisms of phagosome maturation arrest during Mycobacterium tuberculosis infection. While cellular events that culminate in this arrest have been largely ...

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...

PCR (polymerase chain reaction) tests remain the gold standard for diagnosing viruses, but PCR machines—typically found in labs or hospitals—are large and expensive. In cases of common viruses like ...

The ongoing hantavirus outbreak carries disturbing echoes of the early days of COVID: people falling ill on a cruise ship from a relatively unknown pathogen, with no validated test available to ...

Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories to boost the firm’s underperforming stock price, the Wall Street Journal reported, citing people ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The U.S. Centers for Disease Control and Prevention (CDC) currently ...

A lab at the University of Nebraska has developed a test that can detect the virus before symptoms become severe. Now, it's ready to start testing cruise ship passengers returning to the US. As ...

Bio-Rad develops products and solutions for the life sciences research and clinical diagnostic markets and enjoys niche market leadership in diagnostic quality controls, antigens, and digital ...

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, ...

As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...

Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX ...